UMBILICAL CORD BLOOD TRANSPLANTATION
GENETIC MANIPULATION OF HEMATOPOIETIC CELLS
HEMATOPOIETIC STEM CELLS: A REGULATORY OVERVIEW
TOWARDS THE ERADICATION OF RHD HAEMOLYTIC DISEASE
GRANULOCYTE THERAPY REVISTED
DIAGNOSTIC TECHNIQUES IN IMMUNE NEUTROPENIA
Clinical Aspects of Autoimmune Neutropenia
Engineered human antibodies in the diagnosis and possible treatment of neonatal alloimmune thrombocytopenia
HUMAN ANTIBODIES FROM TRANSLOCUS MICE
HUMAN POLYVALENT IMMUNOGLOBULIN IN TREATMENT.
Donor Motivation versus Donor Deferral
Donor recruitment and retention in Denmark
TO GIVE OR NOT TO GIVE, THAT IS THE QUESTION. INFORMATION ON DONOR AND NON-DONOR ATTITUDES.
DETECTION OF IL-2 AND IFN-γ GENE POLYMORPHISMS
A SEMI-AUTOMATED PLATELET CROSS-MATCHING SYSTEM FOR THE MANAGEMENT OF PLATELET REFRACTORINESS
ANTI-MOUSE ANTIBODIES DETECTED USING GTI-PAK 12 KITS.
LONGITUDINAL STUDY INVESTIGATING LINKS BETWEEN HUMAN CYTOMEGALOVIRUS INFECTION AND SYSTEMIC LUPUS ERYTHEMATOSUS
APPROPRIATE USE OF BLOOD PRODUCTS IN THE BLEEDING SURGICAL PATIENT: THE USE OF THE THROMBOELASTOGRAPH TO MONITOR PATIENTS POST CARDIAC SURGERY
DEVELOPMENT OF AN ELISA TO DETERMINE CONCENTRATION OF BRAD-5, A HUMAN MONOCLONAL ANTI-D ANTIBODY, IN HUMAN SERUM SAMPLES.
RECOMBINANT DESIGNER ANTIBODIES IN HPA-1a TYPING
A ONE STEP WHOLE BLOOD HPA-1a TYPING ELISA USING A RECOMBINANT ANTI-HPA-1a
HLA-A TYPING BY RSCA ON A CAPILLARY BASED GENETIC ANALYSER
INHERITANCE OF TWO GLYCOPHORIN C VARIANTS (GPC.Ge AND GPC.Yus) IN AN IRISH FAMILY
AN RHD PSEUDOGENE CONTAINING A 37 BP DUPLICATION AND A NONSENSE MUTATION IS PRESENT IN MOST AFRICANS WITH THE RH D-NEGATIVE BLOOD GROUP PHENOTYPE
DEVELOPMENT OF ERYTHROID CELL SURFACE MARKERS DURING IN VITRO ERYTHROPOIESIS; A COMPARISON OF TWO METHODS
αV INTEGRIN ON ADHERENT CELLS, NEW LIGAND(S) FOR THE ERYTHROCYTE LW GLYCOPROTEIN (ICAM4)
A PHARMACOVIGILANCE STUDY ON REPLENATE® (HIGH PURITY FACTOR VIII) AND REPLENINE® (HIGH PURITY FACTOR IX).
PRECLINICAL EVALUATION OF A TETANUS TOXIOD FrC GENE CONTAINING PLASMID FOR A PHASE II TRIAL OF IDIOTYPIC VACCINATION IN FOLLICULAR LYMPHOMA
IN VITRO VALIDATION OF DENDRITIC CELL IMMUNOTHERAPY PRIOR TO A PHASE I CLINICAL TRIAL FOR BREAST CANCER
A PILOT STUDY OF ATTITUDES TOWARDS BLOOD DONATION IN ASIAN STUDENTS.
BANNING ADDRESSOGRAPH STICKERS ON BLOOD TRANSFUSION SAMPLES: IMPACT ON FREQUENCY OF LABELLING ERRORS
SPECIALIST REGISTRAR TRAINING POST CALMAN
CORE KNOWLEDGE - A TRAINING PROGRAMME FOR ALL STAFF
The Natural History of Transfusion-Transmitted Viruses
Transfusion triggers in the surgical patient.
ACUTE BLOOD LOSS IN CHILDREN
CYTOKINES IN BLOOD COMPONENTS
THROMBOPOIETIN IN CLINICAL AND TRANSFUSION MEDICINE: LOOKBACK AND LOOK FORWARD
RECENT ADVANCES IN THE DIAGNOSIS AND MANAGEMENT OF HDN
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA
TRANSFUSIONS IN INFANCY: CURRENT CONTROVERSIES
THE CLINICAL COURSE OF HCV-RELATED DISEASE IN THE FIRST DECADE OF INFECTION: A PRELIMINARY ANALYSIS OF DATA FROM THE HCV NATIONAL REGISTER
REMOVAL OF ABNORMAL PRION PROTEIN BY PLASMA FRACTIONATION PROCESSES.
FETAL ANAEMIA DUE TO ANTI-K MAY RESULT FROM IMMUNE DESTRUCTION OF EARLY ERYTHROID PROGENITORS
CLONING AND CHARACTERISATION OF RECOMBINANT PLATELET AUTOANTIBODIES FROM A PATIENT WITH POST TRANSFUSION PURPURA
THE ALLOREACTIVE AND AUTOREACTIVE T HELPER CYTOKINE RESPONSES TO THE RhD PROTEIN DIFFER
HLA EPITOPE ANALYSIS AND THE AVOIDANCE OF PLATELET RESISTANCE IN SEVERE APLASTIC ANAEMIA (SAA) PATIENTS
THE IMMUNOGENICITY OF Gov ALLOANTIGENS IS COMPARABLE TO THAT OF THE HPA-5 SYSTEM
TRANSFUSION TRANSMITTED INFECTIONS IN HAEMOPHILIACS
PHENOTYPIC AND FUNCTIONAL CHARACTERISATION OF CORD BLOOD CD34+ DERIVED DENDRITIC CELLS.
ANALYSIS OF LEUCOCYTE SUBSET SPECIFIC EXPRESSION MARKERS USING TAQMAN REAL-TIME QUANTITATIVE PCR.
STABILITY OF HCV RNA IN POOLED PLASMA
THE PREDICTION OF PLATELET RECOVERY FOLLOWING PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
BETTER MANAGEMENT OF BLOOD STOCKS: REPORT ON PHASES 1 & 2 OF THE NATIONAL BLOOD STOCKS PROJECT
ESTABLISHING AN ACCREDITED PLATELET DONOR PANEL TO PROVIDE TRANSFUSION SUPPORT FOR FETOMATERNAL ALLOIMMUNE THROMBOCYTOPENIA
EFFECTIVENESS OF A PROTOCOL IN REDUCING INAPPROPRIATE TRANSFUSION
BETTER BLOOD TRANSFUSION - The Effective Use of Blood Programme
OVERTRANSFUSION IN SURGICAL MANAGEMENT: DO WE PRACTISE WHAT WE PREACH?
PRODUCTION OF PLATELET CONCENTRATES (PCs) TREATED WITH THE PSORALEN S-59 AND UVA LIGHT FOR CLINICAL USE
RELEASE OF SOLUBLE PRION PROTEIN DURING STORAGE OF APHERESIS PLATELET CONCENTRATE.
USE OF AUTOMATED BLOOD COMPONENT SEPARATOR, OPTIPRESS®II: IMPACT ON LEUKODEPLETION OF RED CELLS CONCENTRATE AND PROCESS STANDARDISATION.
PANCYTOPENIA ASSOCIATED WITH MULTIPLE LINEAGE QUININE-DEPENDENT ANTIBODIES
145 THREONINE/METHIONINE VARIANTS OF BACULOVIRUS PRODUCED LIGAND BINDING DOMAIN OF GPIbα SHOW EQUAL BINDING OF vWF AND SUPPORT THE INVOLVEMENT OF THE LEUCINE RICH REPEAT REGION IN vWF BINDING
MAKING GOOD USE OF THE EVIDENCE (SR's)
UK NEQAS (BLTP) - LESSONS LEARNT
Haemovigilance: after 2 years of SHOT, what next?
INACTIVATION OF VIRUSES, BACTERIA, AND LEUKOCYTES IN CELLULAR COMPONENTS USING COMPOUNDS TARGETED TO NUCLEIC ACID.
Changes in haemostatic parameters of methylene blue virally inactivated plasma, cryoprecipitate and cryosupernatant
Cellular Fragments and Prion Protein in Blood Components
NEW APPROACHES TO ENUMERATION OF LEUCOCYTES AND LEUCOCYTE SUBSETS
PCH vs CHAD WITH BIPHASIC HAEMOLYSINS
PCH IS NOT NECESSARILY A PRIMARY CONDITION
2 HOUR TURN-ROUND TIME FOR ISSUING BLOOD IN PATIENTS WITH AIHA
POSITIVE DIRECT ANTIGLOBULIN TESTS IN HAIRY CELL LEUKAEMIA
THE TRANSFUSION OF THREE UNITS OF ABO INCOMPATIBLE BLOOD WITH NO ILL EFFECT
EVALUATION OF SANOFI DIAGNOSTICS PASTEUR SCANGEL SYSTEM FOR RED CELL ANTIBODY DETECTION
COMPARISON OF BIOTEST SOLIDSCREEN II AND AN INHOUSE SOLID PHASE MICROPLATE ANTIGLOBULIN TEST
EVALUATION OF SANOFI PASTEUR SCANCEL
THE MANUAL POLYBRENE TEST WITH SUPPLEMENTARY ANTIGLOBULIN PHASE: A NEGLECTED BUT SUPERIOR TEST COMPLETED WITHIN 15 MINUTES.
VARIABLE INHIBITION OF PLACENTAL IgG TRANSFER IN VITRO DEMONSTRATED WITH DIFFERENT COMMERCIAL IVIgG PREPARATIONS
HIDDEN RED CELL ANTIBODIES: A PROBLEM PARTICULARLY ASSOCIATED WITH THE USE OF COMMERCIAL ANTIBODY IDENTIFICATION PANELS
VALIDATION OF DIFFERENTIAL ADSORPTION OF AUTOANTIBODIES USING NEQAS SERA
A NOVEL COLTON-RELATED ANTIBODY REACTING ONLY WITH Co(a+b+) CELLS
AUTOMATED VERSUS MANUALLY PROCESSED ANTIBODY SCREENING USING CAPTURE READY SCREEN: A COMPARATIVE STUDY
SCOTTISH EXPERIENCE WITH AMNIOCENTESIS SAMPLES FOR FETAL BLOOD GROUP DNA TYPING.
RhD TYPING ON OLYMPUS PK7200
ANTI-M DISCOVERED IN A NON-TRANSFUSED BURNS PATIENT
BINDING AND MOLECULAR ANALYSIS OF TWO RhD ANTIBODIES RECOGNISING epD15
DO 'FIXED' RED CELLS RETAIN BOUND ANTIBODY?
Du SEE A Dweak
USE OF FITC LABELLED ANTI-D AND PE LABELLED ANTI-IgG TO DETERMINE FMH BY FLOW CYTOMETRY.
THE USE OF THE CHEMILUMINESCENCE ASSAY TO PREDICT THE SAFE TRANSFUSION OF SEROLOGICALLY INCOMPATIBLE BLOOD.
THE RH E ANTIGEN (PRO226) AND CYS16 BOTH INFLUENCE RH C ANTIGEN EXPRESSION IN K562 CELLS TRANSDUCED WITH cDNA'S FROM THE RHCE GENE.
Noninvasive prenatal diagnosis of fetal blood group status
DNA-BASED TYPING FOR Rh D, C AND c: SIMULTANEOUS DETECTION OF BOTH MAJOR CAUCASIAN AND BLACK D-NEGATIVE ALLELES
STUDIES OF TWO PARTIAL DS: DMH AND DOL
USE OF A NEGATIVE CONTROL ANTIBODY IN THE QUANTITATION OF FETO-MATERNAL HAEMORRHAGE BY FLOW CYTOMETRY.
AN EXAMPLE OF ANTI-Jra IDENTIFIED IN AN ANTENATAL PATIENT.
CASE REPORT: HDN CAUSED BY ANTI-E.
INCIDENCE OF K ANTIGEN IN GHANAIANS TESTED AT KORLE BU, ACCRA, GHANA
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA - REVIEW OF 17 CASES IN 12 FAMILIES
HLA-A, -B, -DR and -DQ TYPING OF WELSH BONE MARROW DONOR REGISTRY PANEL DONORS BY PCR USING SEQUENCE SPECIFIC PRIMERS
ROUTINE SEROLOGICAL ANALYSIS OF 188 CASES OF ALLEGED IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
DIFFERENTIATION OF COMMON HLA-B*27 ALLELES BY FLOW CYTOMETRY
USING RED CELLS TO SCREEN FOR ANTENATAL PATIENTS FOR HLA ANTIBODIES
FRET FOR DETECTING ANTI-HPA-1a
HLA CLASS II Ab - A MAJOR CONTRIBUTOR TO TRALI
REVIEW OF 13 TRALI CASES
ABSOLUTE COUNTING OF CD34+ CELLS USING THE ISHAGE PROTOCOL.
OTHER HLA ALLELES IN ADDITION TO HLA-DRB3*0101 MAY INFLUENCE ALLOANTIBODY RESPONSES TO HPA-1a
A MODEL SYSTEM FOR THE STUDY OF PLATELET DESTRUCTION IN ALLOIMMUNE THROMBOCYTOPENIA
FATAL COLD TYPE AUTOIMMUNE HAEMOLYTIC ANAEMIA DUE TO ANTI-i IN HAIRY CELL LEUKAEMIA
PLATELET AND LYMPHOCYTE HUMORAL ALLOIMMUNITY IN SEVERE APLASTIC ANAEMIA PATIENTS
PROVIDING B POSITIVE BLOOD FOR B POSITIVE PATIENTS
HYPERHAEMOLYSIS AFTER TRANSFUSION OF ALLOCOMPATIBLE RED CELLS IN MECHANICAL HAEMOLYTIC ANAEMIA: A CLINICALLY IMPORTANT EFFECT OF RED CELL STORAGE?
NEONATAL BLOOD TRANSFUSION AND ALLOCATION OF DONOR PACKS
KLEIHAUER TESTING IN RHESUS POSITIVE WOMEN
AUDIT TO ASSESS TRANSFUSION PROGRAMME PRACTICE IN SICKLE CELL DISEASE (SCD).
AUDIT OF RED CELL TRANSFUSIONS TO NONSURGICAL PATIENTS IN A DISTRICT GENERAL HOSPITAL
RE-AUDIT OF INTENSIVELY TRANSFUSED NEONATES
SHARING OF RED CELL ALIQUOTS AMONG NEONATES
WHO RECEIVES GROUP B NEGATIVE RED CELLS?
STUDY OF RED CELL USAGE BY CLINICAL DIRECTORATE/SPECIALTY
THE PHARMACOKINETICS AND TOLERANCE OF SOLVENT/DETERGENT TREATED HUMAN NORMAL IMMUNOGLOBULIN (i.m.) IN HUMAN NORMAL VOLUNTEERS
AUDIT OF CURRENT BEDSIDE PROCEDURES IN THE HANDLING OF FRESH FROZEN PLASMA (FFP)
DOING THE BLOOD OBS: RATIONAL OR RITUAL PRACTICE.
INCIDENCE OF HLA ALLOIMMUNISATION IN β-THALASSAEMIA AND SICKLE CELL PATIENTS
INTRA-OPERATIVE AUTOLOGOUS BLOOD TRANSFUSION (IAT). CAN WE DO BETTER?
COST OF BLOOD AND CELL SALVAGE. CLINICIANS PERCEPTION
AUDIT
Direct Agglutination Crossmatch At Room Temperature (DRT): The Results Of A NEQAS (BTLP) Questionnaire
A SURVEY OF THE PERCEPTIONS OF NURSING PRACTITIONERS ON THE POLICY OF ADMINISTRATION OF BLOOD IN THE ROYAL HOSPITALS NHS TRUST
OPTHALMIC SURGERY USING AUTOLOGOUS PLATELET CONCENTRATE
EFFECT OF WHITE CELL DEPLETION OF RED CELLS ON POST OP INFECTION RATES IN CARDIAC SURGERY
REFRACTORY HYPERHAEMOLYSIS IN A PATIENT WITH β-THALASSAEMIA MAJOR.
ASSESSMENT OF ERYTHROCYTE DAMAGE BY A PERISTALTIC INFUSION PUMP IN NEONATAL USE
THE NORMAL ISOFORM OF PRION PROTEIN IS FOUND IN HUMAN PLASMA, BUT IS REMOVED BY THE SNBTS PLASMA FRACTIONATION PROCESS
THE DISTRIBUTION OF THE NORMAL ISOFORM OF PRION PROTEIN IN BLOOD
PURIFICATION OF CELLULAR PRION PROTEIN (PrPc) FROM PLATELETS
AN AUDIT OF THE USE OF ALBUMIN IN A DISTRICT GENERAL HOSPITAL.
AN AUDIT OF THE USE OF FRESH FROZEN PLASMA AND CRYOPRECIPITATE.
AN EVALUATION OF A NEW 12-PLACE BLOOD PROCESSING CENTRIFUGE THE SORVALL RC-12BP.
COMPARATIVE STUDY OF IN-LINE FILTER BLOOD COLLECTION PACKS
QUALITY OF LEUCODEPLETED PLASMA PRODUCED BY WHOLE BLOOD FILTRATION
VALIDATION OF VIRUS INACTIVATION BY UV-C IRRADITION OF 4.5% HUMAN ALBUMIN
EVALUATION OF A NOVEL FILTER FOR LEUCOCYTE DEPLETION OF FRESH PLASMA.
VALIDATION OF AN IN-PROCESS FILTER SYSTEM FOR LEUCOCYTE DEPLETION OF RED CELLS
PREPARATION OF LEUCOCYTE DEPLETED BUFFY COAT PLATELETS USING AN IN-LINE FILTER SYSTEM
COAGULASE-NEGATIVE STAPHYLOCOCCAL CONTAMINATION OF WHOLE BLOOD AND ITS COMPONENTS: THE EFFECTS OF LEUCODEPLETION
HOW THE LONDON AND SOUTHEAST ZONE RECONCILED IT'S PROBLEMS.
PLATELETPHERESIS USING THE BAXTER® AMICUS™ APHERESIS SYSTEM.
NEW THRESHOLDS FOR DONOR HAEMOGLOBIN CONCENTRATION (FIRST YEAR'S EXPERIENCE)
IRON STATUS OF DONORS, INCLUDING sTfR LEVELS
VARIABILITY IN FINGER-STICK BLOOD HAEMOGLOBIN CONCENTRATION - A RE-ASSESSMENT
INCREASED ACCURACY IN CuSO4 ANAEMIA SCREENING
BLEEDING DIABETIC DONORS: IS IT SAFE?
MEETING THE NEEDS OF ASIAN DONORS-SUSTAINING THE IMPETUS
HOW RELIABLE ARE WHOLE BLOOD DONORS AS A TEMPORARY SOURCE OF HLA MATCHED PLATELETS?
CHANGING DEMAND FOR A MOBILE TRANSFUSION CENTRE BASED PLASMA EXCHANGE AND RED CELL EXCHANGE SERVICE
RESULTS OF AN OPTIONAL HCV SCREENING PROGRAMME FOR BLOOD TRANSFUSION RECIPIENTS
BRILLIANT RESPONSE TO MASSIVE POST-TRANSFUSION INFECTION INVESTIGATION AT HIGH COST AND NO RETURN
MANAGING BLOOD DONORS WITH UNCONFIRMED REPEAT REACTIVE MICROBIOLOGY RESULTS IN TRENT
DELAYED HAEMOLYTIC TRANSFUSION REACTION MASQUERADING AS TRANSFUSION TRANSMITTED HEPATITIS A INFECTION
SHOULD DISPOSABLE TIPS FOR NAT POOLING BE SUBJECTED TO BATCH PRE-ACCEPTANCE TESTING?
VALIDATION OF PLASMA POOLING FOR NAT TESTING AND RESULT HANDLING IN THE WELSH BLOOD SERVICE
HCV GENOTYPES AND BLOOD DONORS
THE USE OF NWA QUALITY ANALYST SPC SOFTWARE TO CONTROL THE RELEASE OF MICROBIOLOGY RESULTS
NATURAL KILLER CELLS IN BLOOD RECIPIENTS.
HELPER-T CELL EPITOPES ON THE RHD PROTEIN - TOWARDS A PEPTIDE VACCINE FOR PREVENTION OF Rh DISEASE
THE USE OF MYELOID CELL LINES TO DETECT ANTIBODIES IN AUTOIMMUNE NEUTROPENIA
In vitro PROLIFERATIVE RESPONSES OF T CELLS FROM HPA-1a ALLOIMMUNISED WOMEN TOWARDS HPA-1a AND HPA-1b PEPTIDES
IMPACT OF AUTOMATION ON BLOOD TRANFUSION
INTRODUCTION OF A NATIONAL COMPUTER SYSTEM FOR THE RED CELL IMMUNOHAEMATOLOGY LABORATORIES OF THE NATIONAL BLOOD SERVICE
THE WELSH ASSESSMENT OF SEROLOGICAL PROFICIENCY SCHEME (WASPS) AND THE GROWING TREND TOWARDS COMMERCIAL ANTIBODY DETECTION SYSTEMS.
RE-AUDIT OF BLOOD SAMPLE LABELLING AND REQUEST FORM COMPLETION
IS DATA FROM UK NEQAS EXERCISES VALID? RESULTS OF AN ANONYMOUS QUESTIONNAIRE